Tharimmune Inc (NASDAQ:THAR) saw an upside of 21.72% to $0.27 after adding $0.05 on Tuesday. The 5-day average trading volume is 4,841,861 shares of the company’s common stock. It has gained $0.3400 in the past week and touched a new high 2 times within the past 5 days. An average of 1,397,165 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 720,624.
THAR’s 1-month performance is 12.99% or $0.0282 on its low of $0.1903 reached on 09/11/23. The company’s shares have touched a 52-week low of $0.19 and high of $2.65, with the stock’s rally to the 52-week high happening on 02/10/23. YTD, THAR has lost -31.27% or -$0.1245 and has reached a new high 12 times. However, the current price is down -89.89% from the 52-week high price.
Top 5 AI Stocks to Buy for 2023
The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
Click Here to Download the FREE Report.
Sponsored
Valuation Metrics
THAR stock has a beta of 3.04. Moving on to other valuation ratios, the price-to-book (PB) in the most recent quarter is 1.47.
Tharimmune Inc’s quick ratio for the recent period was 3.01, with the current ratio over the same period at 3.01.
Let’s look briefly at Tharimmune Inc (THAR) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 25 September was 64.47% to suggest the stock is trending Neutral, with historical volatility in this time period at 111.73%.
The stock’s 5-day moving average is $0.2355, reflecting a +15.70% or $0.0360 change from its current price. THAR is currently trading +4.61% above its 20-day SMA, -38.30% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 by -30.18% and SMA200 by-39.55%.
Stochastic %K and %D was 38.99% and 36.92% and the average true range (ATR) pointed at 0.0375. The RSI (14) points at 56.38%, while the 14-day stochastic is at 50.10% with the period’s ATR at 0.0330. The stock’s 9-day MACD Oscillator is pointing at 0.0069 and 0.0097 on the 14-day charts.
Analyst Ratings
Analysts offering their rating for THAR stock have a consensus rating for the stock as Hold. Currently, 0 brokerage advisors rate THAR as a “sell,”, while 1 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 0 rates the stock as overweight while 0 have offered a “buy” rating.
What is THAR’s price target for the next 12 months?
Analysts have a consensus price target ranging from a low of $4.00 and a high of $4.00, with their median price target at $4.00. Looking at these predictions, the average price target given by analysts is for Tharimmune Inc (THAR) stock is $4.00.
